BECTY yields 2.49% · JNJ yields 2.14%● Live data
📍 BECTY pulled ahead of the other in Year 1
Combined, BECTY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BECTY + JNJ for your $10,000?
Bechtle AG provides information technology (IT) services primarily in Europe. The company operates in two segments, IT System House & Managed Services, and IT E-Commerce. The IT System House & Managed Services segment offers IT strategy consulting, hardware and software selling, project planning and implementation, system integration, IT services, and training for IT operation. This segment also provides applications for business intelligence, customer relationship management, enterprise resource planning, product lifecycle management, computer-aided design/computer-aided manufacturing, product data management, enterprise content management, document management systems, artificial intelligence. The IT E-Commerce segment provides hardware and software products, and peripherals and accessories that comprises approximately 40,000 products through an online shop and telesales. The company also provides data center, modern workplace, networking, IT security, consulting, professional, managed, training, financial, remarketing, and cloud services, as well as design, development, and implementation of software services. It serves customers in the fields of industry, trade, finance, and the public sector. Bechtle AG was founded in 1983 and is headquartered in Neckarsulm, Germany.
Full BECTY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.